Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000724821 | SCV000331962 | uncertain significance | not provided | 2015-06-12 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000724821 | SCV000531962 | benign | not provided | 2020-03-25 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001084352 | SCV000559762 | likely benign | Charcot-Marie-Tooth disease axonal type 2O | 2024-01-25 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002379108 | SCV002693129 | likely benign | Inborn genetic diseases | 2017-09-22 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Prevention |
RCV003947828 | SCV004761434 | likely benign | DYNC1H1-related disorder | 2022-08-03 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |